Survival Rates of Cervical Cancer Patients in Malaysia

  • Muhamad, Nor Asiah (Institute for Medical Research) ;
  • Kamaluddin, Muhammad Amir (Institute for Medical Research) ;
  • Adon, Mohd Yusoff (Institute for Medical Research) ;
  • Noh, Mohamed Asyraf (Institute for Medical Research) ;
  • Bakhtiar, Mohammed Faizal (Institute for Medical Research) ;
  • Tamim, Nor Saleha Ibrahim (Disease Control Division, Ministry of Health) ;
  • Mahmud, Siti Haniza (Institue for Health System Research) ;
  • Aris, Tahir (Institute for Public Health)
  • Published : 2015.04.14


Cervical cancer is the most common malignant cancer of the female reproductive organs worldwide. Currently, cervical cancer can be prevented by vaccination and detected at an early stage via various screening methods. Malaysia, as a developing country faces a heavy disease burden of cervical cancer as it is the second most common cancer among Malaysian women. This population based study was carried out to fulfil the primary aim of determining the survival rates of Malaysian women with cervical cancer and associated factors. Data were obtained from two different sources namely, the Malaysian National Cancer Registry (MNCR) and National Health Informatics Centre (NHIC) from 1st January 2000 to 31st December 2005. Kaplan Meier analyses were conducted to identify the overall survival rates and median survival time. Differences in survival among different ethnic and age group were compared using the log-rank test. A total of 5,859 patients were included. The median survival time for cervical cancer in this study was 65.8 months and the 5-year survival rate was 71.1%. The overall observed survival rates at 1, 3 and 5 years were 94.1%, 79.3% and 71.1% respectively. The log-rank test finding also showed that there were significant differences in the 5-year survival rate among different ethnic groups. Malays had the lowest survival rate of 59.2% followed by Indians (69.5%) and Chinese (73.8%). The overall 5-year survival rate among patients with cervical cancer in Malaysia is relatively good. Age and ethnic groups remain as significant determining factors for cervical cancer survival rate.


Cervical cancer;survival rate;ethnic group;Malaysia


Supported by : NIH


  1. Abdullah NA, Wan Mahiyuddin WR, Muhammad NA, et al (2013a). Survival rate of breast cancer patients in Malaysia: a population-based study. Asian Pac J Cancer Prev, 14, 4591-4.
  2. Abdullah NN, Al-Kubaisy W, Mokhtar MM (2013b). Health behaviour regarding cervical cancer screening among urban women in Malaysia. Proc Social Behavioral Sciences, 85, 110-7.
  3. Adeeb N, Nur-Azurah A, Ong F, et al (2008). Utility of pap smears and mammograms in midlife urban Malaysian women. Medicine & Health, 3, 59-68.
  4. American Cancer Society. 2011. Global Cancer Facts and Figures 2nd Edition [Online]. Atlanta: American Cancer Society. Available:
  5. American Cancer Society. 2013a. Cancer Facts & Figures 2013 [Online]. Atlanta: American Cancer Society. Available:
  6. American Cancer Society. 2013b. Cervical Cancer [Online]. American Cancer Society. Available: [Accessed March 3 2014].
  7. Ariff KM, Beng KS (2006). Cultural health beliefs in a rural family practice: a Malaysian perspective. Aust J Rural Health, 14, 2-8.
  8. Brinton LA, Tashima KT, Lehman HF, et al (1987). Epidemiology of cervical cancer by cell type. Cancer Res, 47, 1706-11.
  9. Brun JL, Stoven-Camou D, Trouette R, et al (2003). Survival and prognosis of women with invasive cervical cancer according to age. Gynecol Oncol, 91, 395-401.
  10. Cancer Research UK. 2014. Cervical cancer survival statistics [Online]. Available: [Accessed Decembeer 13 2014].
  11. Cheah PL, Looi LM (1999). Carcinoma of the uterine cervix: a review of its pathology and commentary on the problem in Malaysians.
  12. Chen T, Jansen L, Gondos A, et al (2012). Survival of cervical cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage. Acta Oncol, 51, 915-21.
  13. Cheung FY, Mang OW, Law SC (2011). A population-based analysis of incidence, mortality, and stage-specific survival of cervical cancer patients in Hong Kong: 1997-2006. Hong Kong Med J, 17, 89-95.
  14. Domingo EJ, Noviani R, Noor MR, et al (2008). Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Vaccine, 26, 71-9.
  15. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
  16. Fernandez ME, Savas LS, Lipizzi E, et al (2014). Cervical cancer control for Hispanic women in Texas: strategies from research and practice. Gynecol Oncol, 132, 26-32.
  17. Haghshenas M, Golini-Moghaddam T, Rafiei A, et al (2013). Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: a populationbased study. Infect Agent Cancer, 8, 20.
  18. Hartmann KE, Hall SA, Nanda K, et al (2002). U.S. preventive services task force evidence syntheses, formerly systematic evidence reviews. in 'screening for cervical cancer', eds agency for healthcare research and quality (US), Rockville (MD).
  19. Hisham AN, Yip CH (2004). Overview of breast cancer in Malaysian women: a problem with late diagnosis.
  20. Horn LC, Fischer U, Raptis G, et al (2007). Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol, 107, 310-5.
  21. Howell-Jones R, Bailey A, Beddows S, et al (2010). Multisite study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England. Br J Cancer, 103, 209-16.
  22. Hsieh CH, Tsai SJ, Chiou WY, et al (2013). Better survival with three-dimensional conformal radiotherapy than with conventional radiotherapy for cervical cancer: a populationbased study. ISRN Oncol, 2013, 729819.
  23. Ishioka S, Endo T, Hayashi T, et al (2006). Successful delivery after vaginal radical trachelectomy for invasive uterine cervical cancer. Int J Clin Oncol, 11, 146-9.
  24. Karimi-Zarchi M, Mousavi A, Gilani MM, et al (2013). Conservative treatment in early cervical cancer. Int J Biomed Sci, 9, 123-8.
  25. Kyrgiou M, Shafi MI (2010). Invasive cancer of the cervix. Obstetrics Gynaecol Reproductive Med, 20, 147-54.
  26. Lee YY, Choi CH, Kim CJ, et al (2010). Glucose as a prognostic factor in non-diabetic women with locally advanced cervical cancer (IIB-IVA). Gynecol Oncol, 116, 459-63.
  27. Lim G (2006). Clinical oncology in Malaysia: 1914 to present.
  28. Lim GC (2002). Overview of cancer in Malaysia.
  29. Lim GC (2003). Cancer in Malaysia--there is light at the end of the tunnel. Med J Malaysia, 58, 632-5.
  30. Maranga IO, Hampson L, Oliver AW, et al (2013). Analysis of factors contributing to the low survival of cervical cancer patients undergoing radiotherapy in Kenya. PLoS One, 8, 78411.
  31. National Cancer Institute. 2013. SEER Stat Fact Sheets: Cervic Uteri Cancer [Online]. Available: [Accessed April 6 2014].
  32. Razak NA, Mn K, Zubairi YZ, et al (2013). Estimating the fiveyear survival of cervical cancer patients treated in hospital Universiti Sains Malaysia. Asian Pac J Cancer Prev, 14, 825-8.
  33. Romus I, Triningsih FE, Mangunsudirdjo S, et al (2013). Clinicopathology significance of p53 and p63 expression in Indonesian cervical squamous cell carcinomas. Asian Pac J Cancer Prev, 14, 7737-41.
  34. Samant R, Kobeleva S, E C, et al (2010). Evaluating contemporary radiotherapy approaches in the primary treatment of cervical cancer. Int J Gynecol Cancer, 20, 1087-91.
  35. Sankaranarayanan R, Swaminathan R, Jayant K, et al (2011). An overview of cancer survival in Africa, Asia, the Caribbean and Central America: the case for investment in cancer health services. IARC Sci Publ, 257-91.
  36. Sasieni P, Adams J, Cuzick J (2003). Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer, 89, 88-93.
  37. Shepherd J, Peersman G, Weston R, et al (2000). Cervical cancer and sexual lifestyle: a systematic review of health education interventions targeted at women. Health Educ Res, 15, 681-94.
  38. Sumitsawan Y, Srisukho S, Sastraruji A, et al (2011). Cancer survival in Chiang Mai, Thailand, 1993-1997. IARC Sci Publ, 199-209.
  39. Vesco KK, Whitlock EP, Eder M, et al (2011). U.S. preventive services task force evidence syntheses, formerly systematic evidence reviews. in 'screening for cervical cancer: a systematic evidence review for the U.S. Preventive Services Task Force', Eds Agency for Healthcare Research and Quality (US), Rockville (MD),
  40. Vizcaino AP, Moreno V, Bosch FX, et al (2000). International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer, 86, 429-35.<429::AID-IJC20>3.0.CO;2-D
  41. Wong LP, Wong Y, Fau- LowWY, et al (2009). Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study. Singapore Med J, 50, 49-53.
  42. Wong LP, Wong YL, Low WY, et al (2008). Cervical cancer screening attitudes and beliefs of Malaysian women who have never had a pap smear: a qualitative study. Int J Behav Med, 15, 289-92.
  43. Xiang YB, Jin F, Gao YT (2011). Cancer survival in Shanghai, China, 1992-1995. IARC Sci Publ, 55-68.
  44. Yousefi Z, Kazemianfar Z, Kadghodayan S, et al (2013). Less radical surgery for patient with early-stage cervical cancer. Iran Red Crescent Med J, 15, 617-9.

Cited by

  1. Targeting of tubulin polymerization and induction of mitotic blockage by Methyl 2-(5-fluoro-2-hydroxyphenyl)-1H-benzo[d]imidazole-5-carboxylate (MBIC) in human cervical cancer HeLa cell vol.35, pp.1, 2016,